intellectual property

Second judge says US not liable in Moderna COVID-19 vaccine patent case
Second judge says US not liable in Moderna COVID-19 vaccine patent case
Reuters
Moderna Therapeutics
patents
intellectual property
legal
vaccines
COVID-19
Flag link:
Alcon to pay Johnson & Johnson $199 mln to settle eye-laser cases
Alcon to pay Johnson & Johnson $199 mln to settle eye-laser cases
Marketscreener
JNJ
Alcon
intellectual property
legal
Flag link:
Biopharma Needs to Protect more than Crown Jewel IP to Stay Competitive
Biopharma Needs to Protect more than Crown Jewel IP to Stay Competitive
BioSpace
biotech
intellectual property
Flag link:
Cure Pharmaceutical sells drug delivery patents in $20M deal
Cure Pharmaceutical sells drug delivery patents in $20M deal
Fierce Pharma
Cure Pharmaceutical
drug delivery
patents
intellectual property
Flag link:
Boston Scientific pays $85M to settle long-running patent dispute with Nevro
Boston Scientific pays $85M to settle long-running patent dispute with Nevro
Medtech Dive
devices
Medtech
patents
intellectual property
Boston Scientfic
Nevro
Flag link:
A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
Endpoints
vaccines
COVID-19
intellectual property
Europe
India
South Africa
World Trade Organiztion
Flag link:
Moderna vows never to enforce Covid jab patents in policy U-turn
Moderna vows never to enforce Covid jab patents in policy U-turn
Financial Times
Moderna Therapeutics
vaccines
COVID-19
intellectual property
patents
Flag link:
Is the clock ticking on Moderna's patent promise? Activists fear South African patents could hinder vaccine production
Is the clock ticking on Moderna's patent promise? Activists fear South African patents could hinder vaccine production
Endpoints
Moderna Therapeutics
vaccines
COVID-19
South Africa
patents
intellectual property
Flag link:
COVID-19 vaccines and IP waiver proposals: One year on, where are we now?
COVID-19 vaccines and IP waiver proposals: One year on, where are we now?
Biopharma Reporter
intellectual property
vaccines
COVID-19
Flag link:
Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world
Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world
Fierce Pharma
vaccines
COVID-19
Amnesty International
AstraZeneca
BioNTech
JNJ
Moderna Therapeutics
Novavax
Pfizer
intellectual property
Flag link:
Top 7 challenges facing the medical device market
Top 7 challenges facing the medical device market
MedCity News
devices
Medtech
supply chain
regulatory
cybersecurity
intellectual property
device recalls
legal
competition
Flag link:
Roche CEO Schwan joins chorus of pharma execs blasting COVID patent waiver
Roche CEO Schwan joins chorus of pharma execs blasting COVID patent waiver
Fierce Pharma
Roche
Severin Schwan
Pharma CEOs
COVID-19
vaccines
intellectual property
Flag link:
Vaccine waiver talks can make drug firms the heroes, U.S. trade chief says
Vaccine waiver talks can make drug firms the heroes, U.S. trade chief says
Reuters
vaccines
COVID-19
intellectual property
generics
Flag link:
Pfizer calls proposed IP waiver for Covid vaccines a 'distraction' from finding real solutions on access
Pfizer calls proposed IP waiver for Covid vaccines a 'distraction' from finding real solutions on access
Endpoints
Pfizer
intellectual property
patents
COVID-19
vaccines
Flag link:
U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech
U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech
Yahoo/Reuters
Joe Biden
COVID-19
vaccines
patents
China
Russia
intellectual property
Flag link:
Pharma groups slam US decision to support COVID-19 vaccine patent waivers
Pharma groups slam US decision to support COVID-19 vaccine patent waivers
RAPS.org
WTO
Joe Biden
patents
intellectual property
vaccines
COVID-19
Flag link:
Should Novavax Be Worried About Losing IP Rights?
Should Novavax Be Worried About Losing IP Rights?
Motley Fool
vaccines
Novavax
COVID-19
intellectual property
Joe Biden
Flag link:
U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production
U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production
Stat
COVID-19
vaccines
intellectual property
Flag link:
Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver
Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver
Reuters
Pfizer
AstraZeneca
COVID-19
intellectual property
Flag link:
Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies
Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies
Biopharma Reporter
Amgen
Sanofi
patents
antibodies
intellectual property
Flag link:

Pages